Assessment of the total effective xenoestrogen burden in extracts of human placentas

Biomarkers

Volumn 14, Issue 5, 2009, Pages 271-277

  Lopez Espinosa, Maria Jose ^a,b   Silva, Elisabete ^c   Granada, Alicia ^a   Molina Molina, Jose Manuel ^a   Fernandez, Mariana F ^a   Aguilar Garduo, Clemente ^a   Olea Serrano, Fatima ^d   Kortenkamp, Andreas ^c   Olea, Nicolas ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

E Screen; Placenta; Prenatal exposure; Total effective xenoestrogen burden; Yeast Estrogen Screen

Indexed keywords

ESTRADIOL; ESTROGEN DERIVATIVE; SEX HORMONE; UNCLASSIFIED DRUG; XENOESTROGEN; CELL EXTRACT; ESTROGEN; XENOBIOTIC AGENT;

ADULT; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLACENTA; CHEMISTRY; PREGNANCY; STANDARD; TUMOR CELL LINE;

ADULT; BIOLOGICAL ASSAY; CELL EXTRACTS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTROGENS; FEMALE; HUMANS; PLACENTA; PREGNANCY; XENOBIOTICS;

EID: 70149085195     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902893744     Document Type: Article

References (31)

1. Cerrillo I, Granada A, Lopez-Espinosa MJ, Olmos B, Jimenez M, Cano A, Olea N, Fatima Olea-Serrano M. (2005). Endosulfan and its metabolites in fertile women, placenta, cord blood, and human milk. Environ Res 98:233-239
2. Coosen R, Van Velsen FL. (1989). Effects of the beta-isomer of hexachlorocyclohexane on estrogen-sensitive human mammary tumor cells. Toxicol Appl Pharmacol 101:310-318
3. Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM. (2000). Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect 108:723-729
4. Fernandez MF, Aguilar-Garduno C, Molina-Molina JM, Arrebola JP, Olea N. (2008). The total effective xenoestrogen burden, a biomarker of exposure to xenoestrogen mixtures, is predicted by the (anti)estrogenicity of its components. Reprod Toxicol 26:8-12.
5. Fernandez M, Molina-Molina JM, Lopez-Espinosa MJ, Freire C, Campoy C, Ibarluzea J, Torne P, Pedraza V, Olea N. (2007a). Biomonitoring of environmental estrogens in human tissues. Int J Hygiene Environ Health 210:429-432
6. Fernandez MF, Olmos B, Granada A, Lopez-Espinosa MJ, Molina- Molina JM, Fernandez JM, Olea-Serrano F, Olea N. (2007). Human exposure to endocrine disrutping chemicals and prenatal risk factors for cryptorchidism and hypospadias. A nested case-control study. Environ Health Perspect 115 (Suppl. 1):8-14.
7. Fernandez MF, Rivas A, Olea-Serrano F, Cerrillo I, Molina-Molina JM, Araque P, Martinez-Vidal JL, Olea N. (2004). Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect. Anal Bioanal Chem 379:163-170
8. Folmar LC, Hemmer MJ, Denslow ND, Kroll K, Chen J, Cheek A, Richman H, Meredith H, Grau EG. (2002). A comparison of the estrogenic potencies of estradiol, ethinylestradiol, diethylstilbestrol, nonylphenol and methoxychlor in vivo and in vitro. Aquatic Toxicol 60:101-110
9. Hollert H, Durr M, Holtey-Weber R, Islinger M, Brack W, Farber H, Erdinger L, Braunbeck T. (2005). Endocrine disruption of water and sediment extracts in a non-radioactive dot blot/RNAse protection-assay using isolated hepatocytes of rainbow trout. Environ Sci Pollution Res Int 12:347-360
10. Ibarluzea JJ, Fernandez MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ, Exposito J, Lorenzo M, Torne P, Villalobos M, Pedraza V, Sasco AJ, Olea N. (2004). Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 15:591-600.
11. Iyengar GV, Rapp A. (2001). Human placenta as a 'dual' biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 2: Essential minor, trace and other (non-essential) elements in human placenta. Sci Total Environ 280:207-219 (Pubitemid 33014321)
12. Landis JR, Koch GG. (1977). The measurement of observer agreement for categorical data. Biometrics 33:159-174
13. Liu JW, Jeannin E, Picard D. (1999). The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system. Biol Chem 380:1341-1345
14. Lopez-Espinosa MJ, Granada A, Carreno J, Salvatierra M, Olea- Serrano F, Olea N. (2007). Organochlorine pesticides in placentas from Southern Spain and some related factors. Placenta 28:631-638 (Pubitemid 46863185)
15. Olea N, Olea-Serrano F. (1996). Oestrogens and the environment. Eur J Cancer Prev 5:491-496
16. Ostergaard G, Knudsen I. (1998). The applicability of the ADI (Acceptable Daily Intake) for food additives to infants and children. Food Add Contam 15 (Suppl.):63-74.
17. Payne J, Rajapakse N, Wilkins M, Kortenkamp A. (2000). Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 108:983-987
18. Pazos P, Perez P, Rivas A, Nieto R, Botella B, Crespo J, Olea- Serrano F, Fernandez MF, Exposito J, Olea N, Pedraza V. (1998). Development of a marker of estrogenic exposure in breast cancer patients. Adv Exp Med Biol 444:29-40.
19. Rajapakse N, Silva E, Kortenkamp A. (2002). Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110:917-921
20. Rasmussen TH, Nielsen F, Andersen HR, Nielsen JB, Weihe P, Grandjean P. (2003). Assessment of xenoestrogenic exposure by a biomarker approach: Application of the E-Screen bioassay to determine estrogenic response of serum extracts. Environ Health 2:12.
21. Rigby AS. (2000). Statistical methods in epidemiology. Towards an understanding of the kappa coefficient. Disability Rehab 22:339-344
22. Rivas A, Fernandez MF, Cerrillo I, Ibarluzea J, Olea-Serrano MF, Pedraza V, Olea N. (2001). Human exposure to endocrine disrupters: standardisation of a marker of estrogenic exposure in adipose tissue. Acta Pathol Microbiol Immunol Scand (APMIS) 109:185-197 (Pubitemid 32511350)
23. Routledge E, Sumpter J. (1996). Estrogenicity activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15:241-248
24. Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. (1996). Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 104:1296-1300
25. Skaare JU, Tuveng JM, Sande HA. (1988). Organochlorine pesticides and polychlorinated biphenyls in maternal adipose tissue, blood, milk, and cord blood from mothers and their infants living in Norway. Arch Environ Contam Toxicol 17:55-63.
26. Snedecor GW, Cochran WG. (1980). Statistical methods. Iowa: Iowa State University Press, 1980.
27. Soto AM, Fernandez MF, Luizzi MF, Oles Karasko AS, Sonnenschein C. (1997). Developing a marker of exposure to xenoestrogen mixtures in human serum. Environ Health Perspect 105 (Suppl. 3):647-654
28. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. (1995). The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Perspect 103 (Suppl. 7):113-122
29. Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM. (1996). Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res 56:5403-5409
30. Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodovar JM, Pedraza V. (1995). The E-screen assay: A comparison of different MCF7 cell stocks. Environ Health Perspect 103:844-850
31. Whyatt RM, Perera FP. (1995). Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ Health Perspect 103 (Suppl. 6):105-110